foxo4-dri senolytic peptide animal study FOXO4-DRI: Human Trial Status, Cancer Research & Data Class II senolytics inhibit survival
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



























